Injectable Influenza Vaccine

Awarded Award Notice Posted

Solicitation number
SPE2DP22D0002
Agency
Medical Supply Chain Troop Support, Department of Defense
Awarded
to Glaxosmithkline, LLC
Set-aside
No set-aside

Opportunity facts

Contract number
SPE2DP22D0002 Federal IDV award
NAICS code
325412 Pharmaceutical Preparation Manufacturing
PSC
6505 Drugs And Biologicals
Place of performance
United States

Notice details come from SAM.gov. Updated .

About this opportunity

Written by GovTribe AI ·

On February 25, 2022, the Defense Logistics Agency Troop Support Medical awarded contract SPE2DP22D0002 to GLAXOSMITHKLINE LLC for $33,806,616. The contract award was for CLINS 0002, 0004, and 0005 of solicitation SPE2DP-21-R-0131 to provide injectable influenza vaccine for the 2022/2023 flu season.

Notice text

As posted on SAM.gov.

On February 25, 2022, CLINS 0002, 0004, & 0005 of solicitation SPE2DP-21-R-0131 were awarded to GSK for the 2022/2023 Injectable Influenza Vaccine Contract (SPE2DP22D0002).

Awarded contract SPE2DP22D0002 to GLAXOSMITHKLINE LLC for 33803616.00 on 2022-02-25.

Notice history

Notice Type Posted
Injectable Influenza Vaccine Latest Award Notice
Injectable Influenza Vaccine Award Notice
Injectable Influenza Vaccine This notice Award Notice
Injectable Influenza Vaccine Latest solicitation Solicitation
Injectable Influenza Vaccine Original Pre-Solicitation

On GovTribe

Work this opportunity on GovTribe

  • Track it in your pipeline
  • Find teaming partners
  • Similar opportunities
  • Ask GovTribe AI about this opportunity
Try for free Login